Tolmar Inc.
Clinical trials sponsored by Tolmar Inc., explained in plain language.
-
New 3-Month shot aims to control hormones in breast cancer
Disease control OngoingThis study is testing a 3-month injection called TOL2506, given alongside standard hormone pills, to suppress ovarian function in premenopausal women with a common type of breast cancer. The goal is to see if this longer-acting injection effectively lowers hormone levels to help …
Phase: PHASE3 • Sponsor: Tolmar Inc. • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Scientists monitor hormone safety in men on testosterone therapy
Disease control OngoingThis study is checking if a prescription testosterone medication called JATENZO affects how the adrenal glands work in men with low testosterone. About 110 men will take the medication for one year while doctors monitor their hormone levels and look for signs of adrenal problems.…
Phase: PHASE4 • Sponsor: Tolmar Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Cancer researchers track Long-Term safety of Hormone-Blocking drug
Disease control ENROLLING_BY_INVITATIONThis study follows patients with hormone-sensitive breast cancer who completed a previous 48-week trial. It aims to collect safety information on a drug that suppresses ovarian function, given alongside standard hormone therapy, for up to four additional years. The main goal is t…
Phase: PHASE3 • Sponsor: Tolmar Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC